ACADIA PHARMACEUTICALS INC (ACAD) › Cost of RevenueACADIA PHARMACEUTICALS INC (ACAD) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2017: $9.08M2018: $12.38M2019: $11.34M2020: $10.21M2021: $19.14M2022: $10.17M2023: $41.64M2024: $81.84M2025: $89.00M$89.00M2017Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$89.00M+8.7%2024$81.84M+96.6%2023$41.64M+309.6%2022$10.17M-46.9%2021$19.14M+87.5%2020$10.21M-10.0%2019$11.34M-8.3%2018$12.38M+36.4%2017$9.08M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share